These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 19645830)

  • 1. Effect of benazepril on survival and cardiac events in dogs with asymptomatic mitral valve disease: a retrospective study of 141 cases.
    Kittleson M; Rishniw M; Pion P
    J Vet Intern Med; 2009; 23(3):445-6; author reply 447-8. PubMed ID: 19645830
    [No Abstract]   [Full Text] [Related]  

  • 2. Concerns about "Comparative adverse cardiac effects of pimobendan and benazepril monotherapy in dogs with mild degenerative mitral valve disease".
    Corcoran B; Culshaw G; Dukes-McEwan J; French A; Smith S; Swift S
    J Vet Intern Med; 2008; 22(2):243; author reply 245. PubMed ID: 18371020
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of benazepril on survival and cardiac events in dogs with asymptomatic mitral valve disease: A retrospective study of 141 cases.
    Kittleson M; Rishniw M; Pion P; Kass P
    J Vet Intern Med; 2009; 23(5):953-4; author reply 955-6. PubMed ID: 19737176
    [No Abstract]   [Full Text] [Related]  

  • 4. Benazepril in dogs with asymptomatic mitral valve disease.
    Brennan M; Stavisky J
    Vet Rec; 2015 Oct; 177(15):392. PubMed ID: 26475899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concerns about "Comparative adverse cardiac effects of pimobendan and benazepril monotherapy in dogs with mild degenerative mitral valve disease: a prospective, controlled, blinded and randomized study".
    Le Bobinnec G
    J Vet Intern Med; 2008; 22(2):243-4; author reply 245-6. PubMed ID: 18371019
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of benazepril on survival and cardiac events in dogs with asymptomatic mitral valve disease: a retrospective study of 141 cases.
    Pouchelon JL; Jamet N; Gouni V; Tissier R; Serres F; Carlos Sampedrano C; Castaignet M; Lefebvre HP; Chetboul V
    J Vet Intern Med; 2008; 22(4):905-14. PubMed ID: 18482278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of pimobendan or benazepril hydrochloride on survival times in dogs with congestive heart failure caused by naturally occurring myxomatous mitral valve disease: the QUEST study.
    Häggström J; Boswood A; O'Grady M; Jöns O; Smith S; Swift S; Borgarelli M; Gavaghan B; Kresken JG; Patteson M; Ablad B; Bussadori CM; Glaus T; Kovacević A; Rapp M; Santilli RA; Tidholm A; Eriksson A; Belanger MC; Deinert M; Little CJ; Kvart C; French A; Rønn-Landbo M; Wess G; Eggertsdottir AV; O'Sullivan ML; Schneider M; Lombard CW; Dukes-McEwan J; Willis R; Louvet A; DiFruscia R
    J Vet Intern Med; 2008; 22(5):1124-35. PubMed ID: 18638016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative adverse cardiac effects of pimobendan and benazepril monotherapy in dogs with mild degenerative mitral valve disease: a prospective, controlled, blinded, and randomized study.
    Chetboul V; Lefebvre HP; Sampedrano CC; Gouni V; Saponaro V; Serres F; Concordet D; Nicolle AP; Pouchelon JL
    J Vet Intern Med; 2007; 21(4):742-53. PubMed ID: 17708394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re: Efficacy of spironolactone on survival in dogs with naturally occurring mitral regurgitation caused by myxomatous mitral valve disease.
    Kittleson MD; Bonagura JD
    J Vet Intern Med; 2010; 24(6):1245-6; author reply 1247-8. PubMed ID: 21054535
    [No Abstract]   [Full Text] [Related]  

  • 10. Hydralazine Therapy for severe mitral regurgitation in a dog.
    Kittleson MD; Hamlin RL
    J Am Vet Med Assoc; 1981 Nov; 179(9):903-5. PubMed ID: 7341606
    [No Abstract]   [Full Text] [Related]  

  • 11. Survival and echocardiographic data in dogs with congestive heart failure caused by mitral valve disease and treated by multiple drugs: a retrospective study of 21 cases.
    de Madron E; King JN; Strehlau G; White RV
    Can Vet J; 2011 Nov; 52(11):1219-25. PubMed ID: 22547843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of monotherapy with benazepril, an angiotensin converting enzyme inhibitor, in dogs with naturally acquired chronic mitral insufficiency.
    Kitagawa H; Wakamiya H; Kitoh K; Kuwahara Y; Ohba Y; Isaji M; Iwasaki T; Nakano M; Sasaki Y
    J Vet Med Sci; 1997 Jul; 59(7):513-20. PubMed ID: 9271444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic management of myxomatous mitral valve disease in dogs.
    Atkins CE; Häggström J
    J Vet Cardiol; 2012 Mar; 14(1):165-84. PubMed ID: 22386553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [ACE inhibitors in dogs with subclinical chronic mitral insufficiency].
    Kvart C; Häggström J; Pedersen HD
    Tijdschr Diergeneeskd; 2003 Feb; 128(3):76-7. PubMed ID: 12616901
    [No Abstract]   [Full Text] [Related]  

  • 15. Oral hydralazine therapy for chronic mitral regurgitation in the dog.
    Kittleson MD; Eyster GE; Olivier NB; Anderson LK
    J Am Vet Med Assoc; 1983 Jun; 182(11):1205-9. PubMed ID: 6863134
    [No Abstract]   [Full Text] [Related]  

  • 16. A QUEST begins.
    Oyama MA
    J Vet Intern Med; 2008; 22(5):1076-8. PubMed ID: 18844829
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacokinetics of nicorandil in dogs with mild mitral regurgitation.
    Fukunaga K; Fujii Y; Chiba N; Ueshima A; Wakao Y; Mishima K; Fujiwara M; Orito K
    Res Vet Sci; 2011 Feb; 90(1):95-8. PubMed ID: 20488500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of spironolactone on survival in dogs with naturally occurring mitral regurgitation caused by myxomatous mitral valve disease.
    Bernay F; Bland JM; Häggström J; Baduel L; Combes B; Lopez A; Kaltsatos V
    J Vet Intern Med; 2010; 24(2):331-41. PubMed ID: 20102506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term hemodynamic and neuroendocrine effects of pimobendan and benazapril in dogs with myxomatous mitral valve disease and congestive heart failure.
    Häggström J; Lord PF; Höglund K; Ljungvall I; Jöns O; Kvart C; Hansson K
    J Vet Intern Med; 2013; 27(6):1452-62. PubMed ID: 24128373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An update on treatment and prognostic indicators in canine myxomatous mitral valve disease.
    Häggström J; Höglund K; Borgarelli M
    J Small Anim Pract; 2009 Sep; 50 Suppl 1():25-33. PubMed ID: 19765217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.